Brainsway IPO four times oversubscribed

This is the first time that an IPO by a biomedical company closed at the top of the price range.

Brainsway Ltd., which is developing a non-invasive magnetic therapy for clinical depression, yesterday completed the public phase of its IPO on the Tel Aviv Stock Exchange (TASE). The company raised NIS 33 million in shares and warrants, at a company value of NIS 110 million.

The offering was oversubscribed more than fourfold at the maximum price. This is the first time that an IPO by a biomedical company closed at the top of the price range. In the institution tender last week, the company received orders for 80% of the offering, which was oversubscribed 1.4-fold.

Clal Finance Underwriting Ltd. and Gaon Underwriting and Investment Ltd. were the underwriters.

Published by Globes [online], Israel business news - www.globes.co.il - on January 2, 2007

© Copyright of Globes Publisher Itonut (1983) Ltd. 2006

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
MORE FROM GLOBES
Twitter Facebook Linkedin RSS Newsletters גלובס